Tissue Regenix executive chairman John Samuel stands down.

Writer,

Archived article

Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.

Regenerative medical devices company Tissue Regenix said executive chairman John Samuel had stood down.

Current director Jonathan Glenn had been appointed as chairman on an interim basis.

At 8:48am: (LON:TRX) Tissue Regenix Group PLC share price was +0.06p at 0.63p

  •